Catalyst
Slingshot members are tracking this event:
Genfit (GNFT) Phase 2 program targeting fibrosis and cirrhosis plans for preclinical regulatory clearance in third quarter of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 10, 2017
Occurred Source:
http://www.genfit.com/wp-content/uploads/2017/10/GENFIT-Overview-OCTOBER-2017.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Fibrosis, Cirrhosis